Selecta Biosciences fully repays debt under loan agreement with Oxford Finance and Silicon Valley Bank

Cartesian Therapeutics, Inc.

Paid all outstanding amounts under Loan and Security Agreement dated Aug 31, 2020 (as amended).
Accrued interest and prepayment penalty included; all obligations discharged in full.
All unfunded commitments terminated; liens and security interests automatically released.
Warrants previously issued to Oxford and Silicon Valley Bank remain outstanding.
No financial amounts disclosed; company no longer has debt obligations under this agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.